Research Site

Lai Chi Kok

1 studies enrolling now · 2 studies all time

What they study most

Hormone-Sensitive Prostate Cancer, Non-small Cell Lung Cancer

Studies at this site

• Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer — Recruiting now
• Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency — Running, not enrolling